Advertisement

Type of anticoagulation therapy in oldest old, frail people with atrial fibrillation: Prescription modification over time. Authors' Reply

      We would like to thank you for the opportunity to address the issues raised by A.Watanabe in his Letter to the Editor [
      • Watanabe A.
      Type of anticoagulation therapy in oldest old, frail people with atrial fibrillation.
      ] and to clarify some methodological and analytical aspects of our study, while thanking him for his interest in our paper.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to European Journal of Internal Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Watanabe A.
        Type of anticoagulation therapy in oldest old, frail people with atrial fibrillation.
        Eur J Intern Med. 2021; https://doi.org/10.1016/j.ejim.2021.05.007
        • Calsolaro V.
        • Okoye C.
        • Antognoli R.
        • Dell'Agnello U.
        • Calabrese A.M.
        • Monzani F.
        Long-term effectiveness and safety of anticoagulation therapy in oldest old, frail people with atrial fibrillation.
        Eur J Intern Med. 2021; 86: 91-97https://doi.org/10.1016/j.ejim.2021.01.020